A Randomized Comparison of Dihydroartemisinin-Piperaquine and Artesunate-Amodiaquine Combined With Primaquine for Radical Treatment of Vivax Malaria in Sumatera, Indonesia — Ayodhia Pitaloka Pasaribu (2013) | RDL Network
A Randomized Comparison of Dihydroartemisinin-Piperaquine and Artesunate-Amodiaquine Combined With Primaquine for Radical Treatment of Vivax Malaria in Sumatera, Indonesia
The Journal of Infectious Diseases 208(11): 1906-1913
Article 2013 English
Authors
AP
Ayodhia Pitaloka Pasaribu
WC
Watcharee Chokejindachai
CS
Chukiat Sirivichayakul
Abstract
1 min read
Background. A high prevalence of chloroquine-resistant Plasmodium vivax in Indonesia has shifted first-line treatment to artemisinin-based combination therapies, combined with primaquine (PQ) for radical cure. Which combination is most effective and safe remains to be established.
Cindy S. Chu, Aung Pyae Phyo, Khin Maung Lwin, Htun Htun Win, Thida San, Aye Aye Aung, Rattanaporn Raksapraidee, Verena I. Carrara, Germana Bancone, James A Watson, Kerryn A. Moore, Jacher Wiladphaingern, Stéphane Proux, Kanlaya Sriprawat, Markus Winterberg, Phaik Yeong Cheah, Amy L Chue, Joel Tärning, Mallika Imwong, François Nosten, Sir Nicholas White
Cindy S. Chu, Aung Pyae Phyo, Claudia Turner, Htun Htun Win, Naw Pet Poe, Widi Yotyingaphiram, Suradet Thinraow, Pornpimon Wilairisak, Rattanaporn Raksapraidee, Verena I. Carrara, Moo Kho Paw, Jacher Wiladphaingern, Stéphane Proux, Germana Bancone, Kanlaya Sriprawat, Sue J. Lee, Atthanee Jeeyapant, James A Watson, Joel Tärning, Mallika Imwong, François Nosten, Sir Nicholas White
Borimas Hanboonkunupakarn, Elizabeth A. Ashley, Podjanee Jittamala, Joel Tärning, Sasithon Pukrittayakamee, Warunee Hanpithakpong, Palang Chotsiri, Thanaporn Wattanakul, Salwaluk Panapipat, Sue J. Lee, Nicholas Day, Sir Nicholas White
Ghulam Rahim Awab, Sasithon Pukrittayakamee, Mallika Imwong, Arjen M. Dondorp, Charles J. Woodrow, Sue Jean Lee, Nicholas Day, Pratap Singhasivanon, Sir Nicholas White, Faizullah Kaker
Discussion(0)
No comments yet. Be the first to comment.